AstraZeneca

ASTRAZEN.NS

Tags: IN Healthcare Drug Manufacturers - Specialty & Generic

AstraZeneca Pharma India Limited Price (ASTRAZEN.NS)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

25,000,000

(0)%

Market Cap of AstraZeneca (ASTRAZEN.NS)

Market cap:

As of , ASTRAZEN.NS has a market cap of . This makes ASTRAZEN.NS the 333th most valuable company in the IN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brands; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brands. The company also offers p... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $4800.15-8139
Market Cap 192.25B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Dr. Sanjeev Kumar Panchal
IPO Date: July, 01, 2002
Country: IN
Currency: INR
Headquaters: No Data
Employees: 940

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: